1- Sackett DL. Compliance with therapeutic regimens. Baltimore: The John Hopkins University Press; 1979, p.1-6.
2- Briesacher BA, Andrade SE., Fouayzi H, Chan KA. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008; 28: 437–443.
3- Curtis JR, Xi J, Westfall AO, Cheng H, Lyles K, Saag KG, Delzell E. Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis. Med Care. 2009; 47:334–341.
4- Lawrence DB, Ragucci KR, Long DB, Parris BS, Helfer LA. Relationship of oral antihyperglycemic (sulfonylurea or met-formin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management pro-gram. J Manag Care Pharm 2006;12:466-71.
5- Ho PM Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ. Effect of medication non-adherence on hospitalization and mortality among patients with di-abetes mellitus. Arch Intern Med 2006; 166:1836-1841.
6- Lee WC, Balu S, Cbden D, Joshi AV, Pashos CL. Prevalence and economic consequences of medication adherence in diabetes: a systematic literature review. Manag Care Interface 2006; 19, 31–41.
7- World Health Organization Report. Sabaté, E., ed. Adherence to Long-Term Therapies, Evidence for Action, Geneva, Switzerland, 2003.
8- Reach G. The role of habit in the adherence to medical treatment. Diabetic Medicine, 2005; 22:415-20.
9- Park DC, Kidder DP. Prospective memory and medication adherence, In: Prospective Memory: Theory and Applications, Brandimonte M et al., eds, Lawrence Erlbaum Associates, 1996.
10- Reach G. Pourquoi se soigne-t-on, Enquête sur la rationalité morale de l’observance, Préface de Pascal Engel, Le Bord de l’Eau, 2007.
11- Livet P. Emotions et rationalité morale. Paris, P.U.F., Collection Sociologies; 2002.
12- Engel P. Les croyances. In : Notions de philosophie, sous la direction de D. Kambouchner, Editions Folio, Gallimard, 1995, p. 25.
13- Meichenbaum D Turk DC. Factors affecting adherence, In: Facilitating Treatment Adherence, Plenum Press, New York & London, 1987, p. 47.
14- Davidson D. Actions, reasons and causes. Journal of Philosophy. 1963. In : Essays on actions and events. Oxford: Clarendon Press; 2001. p. 3-19.
15- Reach G. Application de la théorie causale de l’action à l’analyse de la non-observance thérapeutique. Presse Médicale. 2000 ; 29, 1939-1946.
16- Story GW, Vlaev I, Seymour B, Darzi A, Dolan RJ. Does temporal discounting explain unhealthy behavior? A systematic review and reinforcement learning perspective. Front Behav Neurosci. 2014;8:76.
17- Parfit D. Reasons and persons. Oxford: Clarendon Press; 1984. p. 313-4.
18- Wamala S, Merlo J, Bostrom G, Hogstedt C, Agren G. Socioeconomic disadvantage and primary non-adherence with medication in Sweden. Int J Qual Health Care. 2007;19:134-40.
19- Girerd X, Hanon O, Anagnostopoulos K, Ciupek C, Mourad JJ, Consoli S. Evaluation de l’observance du traitement anti-hypertenseur par un questionnaire : mise au point et utilisation dans un service spécialisé. Presse Médicale. 2001; 30 : 1044-48
20- Reach G. Obedience and motivation as mechanisms for adherence to medication. A study in obese type 2 diabetic patients. Patient Prefer Adherence. 2011;5:523-31.
21- Fogarty JS, Youngs GA Jr. Psychological reactance as a factor in patient noncompliance with medication taking: a field experiment. J Appl Soc Psychol. 2000;30:2365–2391.
22- Barrier PA, Li JT, Jensen NM. Two words to improve physician-patient communication: what else? Mayo Clin Proc. 2003;78:211-4.
23- Reach G. Patient autonomy in chronic care: solving a paradox. Patient Prefer Adherence. 2013;8:15-24.
24- Safran DG, Taira DA, Rogers WH, Kosinski M, Ware JE, Tarlov AR. Linking primary care performance to outcomes of care. J Fam Pract. 1998;47:213-20.
En 5 points
Obésité : suivi d’un patient sous aGLP-1
Cas clinique
La fasciite nécrosante
Mise au point
La périménopause
Mise au point
La sclérose en plaques